Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Clinical Study of Capecitabine in Combination With Mitomycin C as First-Line Treatment in Patients With Metastatic Breast Cancer

NCT01196455 is registered in ClinicalTrials.gov with Croatian Cooperative Group for Clinical Research in Oncology as lead sponsor.

NCT NCT01196455
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01196455 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Clinical Study of Capecitabine in Combination With Mitomycin C as First-Line Treatment in Patients With Metastatic Breast Cancer
Lead sponsor
Croatian Cooperative Group for Clinical Research in Oncology
Phase
Phase 2
Overall status
Unknown status
Start date
March 31, 2006
Completion date
Not reported
Enrollment
39 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, metastasis